Transcriptional interferences between normal or mutant androgen receptors and the activator protein 1 - Dissection of the androgen receptor functional domains

Endocrinology

Volumn 140, Issue 1, 1999, Pages 350-357

  Lobaccaro, Jean Marc ^a,e   Poujol, Nicolas ^a,b   Térouanne, Béatrice ^a   Georget, Virginie ^a   Fabre, Stéphane ^c   Lumbroso, Serge ^a,b   Sultan, Charles ^a,b,d  

^a INSERM   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c CNRS   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; MUTANT PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANDROGEN INSENSITIVITY SYNDROME; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; LIGAND BINDING; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; VAS DEFERENS;

EID: 0032944324     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.1.6418     Document Type: Article

References (47)

1. 1. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
2. 2. Marivoet S, Vandijck P, Verhoeven G, Heyns W 1992 Interaction of the 90-kDa heat shock protein with native and in vitro translated androgen receptor and receptor fragments. Mol Cell Endocrinol 88:165-174
3. 3. Simental JA, Sar M, Lane MV, French FS, Wilson EM 1991 Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 266:510-518
4. 4. Jenster G, van der Korput HAGM, van Vroonhoven C, van der Kwast TH, Brinkmann AO 1991 Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol 5:1396-1404
5. 5. Lobaccaro JM, Poujol N, Chiche L, Lumbroso S, Brown TR, Sultan C 1996 Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations. Mol Cell Endocrinol 116:137-147
6. 6. Bubulya A, Wise SC, Shen XQ, Burmeister LA, Shemshedini L 1996 c-jun can mediate androgen receptor-induced transactivation. J Biol Chem 271:24583-24589
7. 7. Sato N, Sadar MD, Bruchovsky N, Saatcioglu F, Rennie PS, Sato S, Lange PH, Gleave ME 1997 Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J Biol Chem 272:17485-17494
8. 8. Aarnisalo P, Palvimo JJ, Janne OA 1998 CREB-binding protein in androgen receptor-mediated signaling. Proc Natl Acad Sci USA 95:2122-2127
9. 9. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG 1996 A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414
10. 10. Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita F 1986 Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem Biophys Res Commun 135:397-402
11. 11. Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemera D, Hartshorne DJ 1989 Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159:871-877
12. 12. Brown TR, Lubahn DB, Wilson EM, French FS, Migeon CJ, Corden JL 1990 Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity. Mol Endocrinol 4:1759-1772
13. 13. Lobaccaro JM, Belon C, Lumbroso S, Olewniczack G, Carré-Pigeon F, Job JC, Chaussain JL, Toublanc JE, Sultan C 1994 Molecular prenatal diagnosis of partial androgen insensitivity syndrome based on the Hind III polymorphism of the androgen receptor gene. Clin Endocrinol (Oxf) 40:297-302
14. 14. Lumbroso S, Lobaccaro JM, Belon C, Martin-Coignard D, Chaussain JL, Sultan C 1993 A new mutation within the DNA-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome and positive receptor-binding activity. Fertil Steril 60:814-819
15. 15. Lobaccaro JM, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Heron JF, Pujol H, Sultan C 1993 A second instance of male breast cancer linked to a germline mutation of the androgen receptor gene. Nat Genet 5:109-110
16. 16. Sinisi A, Lobaccaro JM, Lumbroso S, Pasquali D, Poujol N, Sultan C, Bellastella A 1996 Partial androgen insensitivity due to androgen receptor gene DNA binding domain point mutation in two prepubertal brothers. Horm Res [Suppl] 46:116
17. 17. Wilson CM, Mcphaul MJ 1994 A and B forms of the androgen receptor are present in human genital skin fibroblasts. Proc Natl Acad Sci USA 91:1234-1238
18. 18. Philips A, Chalbos D, Rochefort H 1993 Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J Biol Chem 268:14103-14108
19. 19. Poujol N, Lobaccaro JM, Chiche L, Lumbroso S, Sultan C 1997 Functional and structural analysis of R607Q and R608K androgen receptor substitutions associated with male breast cancer. Mol Cell Endocrinol 130:43-47
20. 20. Fabre S, Manin M, Pailhoux E, Veyssière G, Jean C 1994 Identification of a functional androgen response element in the promoter of the gene for the androgen-regulated aldose reductase-like protein specific to the mouse vas deferent. J Biol Chem 269:5857-5864
21. 21. Astruc ME, Chabret C, Bali P, Gagne D, Pons M 1995 Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1 mediated response: involvement of the estrogen receptor. Endocrinology 136:824-832
22. 22. Lobaccaro JM, Lumbroso JM, Poujol N, Georget V, Brinkmann AO, Malpuech G, Sultan C 1995 Complete androgen insensitivity syndrome due to a new frameshift deletion in exon 4 of the androgen receptor gene: functional analysis of the mutant receptor. Mol Cell Endocrinol 111:21-28
23. 23. van Laar JH, Voorhost-Ogink MM, Zegers ND, Boersma WJA, Claassen E, van der Korput JAGM, Ruizeveld de Winter JA, Van der Kwast TH, Mulder E, Trapman J, Brinkmann AO 1989 Characterization of polyclonal antibodies against the N-terminal domain of the human androgen receptor. Mol Cell Endocrinol 67:29-38
24. 24. Georget V, Lobaccaro J, Térouanne B, Mangeat P, Nicolas J, Sultan C 1997 Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor. Mol Cell Endocrinol 129:17-26
25. 25. Jenster G, Deruiter PE, Vanderkorput HAGM, Kuiper GGJM, Trapman J, Brinkmann AO 1994 Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry 33:14064-14072
26. 26. Haystead TAJ, Sim ATR, Carling D, Honnor RC, Tsukitani Y, Cohen P, Hardie DG 1989 Effects of the tumor promotor okadaic acid on intracellular protein phosphorylation and metabolism. Nature 337:78-81
27. 27. Young CY, Murtha PE, Zhang J 1994 Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line. Oncol Res 6:203-210
28. 28. Lumbroso S, Lobaccaro JM, Georget V, Leger J, Poujol N, Terouanne B, Evainbrion D, Czernichow P, Sultan C 1996 A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance. J Clin Endocrinol Metab 81:1984-1988
29. 29. Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BAJ, Stratton MR 1992 A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 2:132-134
30. 30. Brinkmann A, Jenster G, Risstalpers C, Vanderkorput H, Bruggenwirth H, Boehmer A, Trapman J 1996 Molecular basis of androgen insensitivity. Steroids 61:172-175
31. 31. Quigley CA, Debellis A, Marschke KB, Elawady MK, Wilson EM, French FS 1995 Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271-321
32. 32. Bruggenwirth HT, Boehmer ALM, Lobaccaro JM, Chiche L, Sultan C, Trapman J, Brinkmann AO 1998 Substitution of Ala(564) in the first zinc cluster of the deoxyribonucleic acid (DNA)-binding domain of the androgen receptor by Asp, Asn, or Leu exerts differential effects on DNA binding. Endocrinology 139:103-110
33. 33. Kallio PJ, Palvimo JJ, Janne OA 1996 Genetic regulation of androgen action. Prostate 45-51
34. 34. Rodien P, Mebarki F, Mowszowicz I, Chaussain JL, Young J, Morel Y, Schaison G 1996 Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. J Clin Endocrinol Metab 81:2994-2998
35. 35. Reinikainen P, Palvimo JJ, Janne OA 1996 Effects of mitogens on androgen receptor-mediated trans activation. Endocrinology 137:4351-4357
36. 36. Kallio PJ, Poukka H, Moilanen A, Janne OA, Palvimo JJ 1995 Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol Endocrinol 9:1017-1028
37. 37. Deruiter PE, Teuwen R, Trapman J, Dijkema R, Brinkmann AO 1995 Synergism between androgens and protein kinase-c on androgen-regulated gene expression. Mol Cell Endocrinol 110:R1-R6
38. 38. Fabre S, Darne C, Veyssiere G, Jean C 1996 Protein kinase C pathway potentiates androgen-mediated gene expression of the mouse vas deferens specific aldose reductase-like protein (MVDP). Mol Cell Endocrinol 124:79-86
39. 39. Chamberlain NL, Whitacre DC, Miesfeld RL 1996 Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J Biol Chem 271:26772-26778
40. 40. Almlof T, Gustafsson JA, Wright APH 1997 Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor. Mol Cell Biol 17:934-945
41. 41. Schneikert J, Peterziel H, Defossez PA, Klocker H, Delaunoit Y, Cato ACB 1996 Androgen receptor-ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression. J Biol Chem 271:23907-23913
42. 42. Palvimo JJ, Reinikainen P, Ikonen T, Kallio PJ, Moilanen A, Janne OA 1996 Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem 271:24151-24156
43. 43. Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P, Cato ACB 1994 A distinct modulating domain in glucorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 13:4087-4095
44. 44. Furey W, Robbins A, Clancy L, Winge D 1986 Crystal structure of Cd, Zn metallothionein. Science 231:704-710
45. 45. Scheena M, Freedman LP, Yamamoto KR 1989 Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes Dev 3:1590-1601
46. 46. Wise SC, Burmeister LA, Zhou XF, Bubulya A, Oberfield JL, Birrer MJ, Shemshedini L 1998 Identification of domains of c-Jun mediating androgen receptor transactivation. Oncogene 16:2001-2009
47. 47. Lubahn DB, Brown TR, Simental JA, Higgs HN, Migeon CJ, Wilson EM, French FS 1989 Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA 86: 9534-9538